Xlife Sciences AG/Fr. XLS
08:00
10:05
12:10
14:15
16:20
1D1W1MYTD1Y5YMAX
About Xlife Sciences AG
Xlife Sciences AG is a Swiss-based company focused on developing and advancing healthcare and life sciences technologies. It operates primarily in the biotechnology and medical technology sectors, concentrating on early-stage life science projects with significant potential in pharmaceuticals, medical devices, diagnostics, and digital health solutions. The company collaborates with research institutions and industry experts to foster innovation and accelerate the commercialization of health-related technologies. Headquartered in Zurich, Switzerland, Xlife Sciences leverages a strategic geographic location to engage with European research hubs and industry partners. The company's unique approach involves investing in and nurturing a diverse portfolio of projects to diversify risk and maximize value creation.
Ticker
Fr. XLS
Sector
Primary listing
XSWX
Employees
17
Headquarters
Zurich, Switzerland
Website
XLS Metrics
BasicAdvanced
CHF 122M
4.68
CHF 4.54
0.34
-
Price and volume
Market cap
CHF 122M
Beta
0.34
52-week high
CHF 28.00
52-week low
CHF 15.75
Average daily volume
3.1K
Financial strength
Current ratio
1.079
Quick ratio
1.068
Long term debt to equity
13.764
Total debt to equity
15.076
Interest coverage (TTM)
-37.39%
Profitability
EBITDA (TTM)
-3.461
Gross margin (TTM)
62.17%
Net profit margin (TTM)
3,663.79%
Operating margin (TTM)
-2,317.98%
Effective tax rate (TTM)
-23.39%
Revenue per employee (TTM)
CHF 50,000
Management effectiveness
Return on assets (TTM)
-2.32%
Return on equity (TTM)
6.62%
Valuation
Price to earnings (TTM)
4.678
Price to revenue (TTM)
144.566
Price to book
0.4
Price to tangible book (TTM)
2.89
Price to free cash flow (TTM)
-507.16
Free cash flow yield (TTM)
-0.20%
Free cash flow per share (TTM)
-0.042
Growth
Revenue change (TTM)
-15.24%
Earnings per share change (TTM)
74.16%
3-year revenue growth (CAGR)
-0.96%
3-year earnings per share growth (CAGR)
-15.20%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Xlife Sciences AG stock?
Xlife Sciences AG (XLS) has a market cap of Fr.122M as of February 21, 2026.
What is the P/E ratio for Xlife Sciences AG stock?
The price to earnings (P/E) ratio for Xlife Sciences AG (XLS) stock is 4.68 as of February 21, 2026.
Does Xlife Sciences AG stock pay dividends?
No, Xlife Sciences AG (XLS) stock does not pay dividends to its shareholders as of February 21, 2026.
When is the next Xlife Sciences AG dividend payment date?
Xlife Sciences AG (XLS) stock does not pay dividends to its shareholders.
What is the beta indicator for Xlife Sciences AG?
Xlife Sciences AG (XLS) has a beta rating of 0.34. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.